Offer - Urjas Oil for just ₹ 1 X
Tripin OM Tablet is a commercial drug that is prescribed in the form of Tablet. Secondary and off-label uses of Tripin OM Tablet have also been mentioned below.
The optimal dosage of Tripin OM Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Common side effects of Tripin OM Tablet include Upper respiratory tract infection. Apart from the aforementioned side effects, Tripin OM Tablet can also lead to other problems, which have been listed below. Such side effects of Tripin OM Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
In addition, Tripin OM Tablet's effect is Safe during pregnancy and Safe for lactating mothers. In addition, Tripin OM Tablet's effects on the liver, heart and kidney are discussed below in the Tripin OM Tablet related warnings section.
Tripin OM Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Tripin OM Tablet in conditions like Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension), Low Blood Pressure (Hypotension). Other conditions have been mentioned below in the Tripin OM Tablet contraindications section.
Besides this, Tripin OM Tablet may also have severe interaction with some medicines. See below for a complete list.
In addition to the above precautions for Tripin OM Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Tripin OM Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Tripin OM Tablet safe for pregnant women?
Tripin Om is safe to take during pregnancy.
Is the use of Tripin OM Tablet safe during breastfeeding?
Tripin Om is completely safe for breastfeeding women.
What is the effect of Tripin OM Tablet on the Kidneys?
Tripin Om may have mild side effects on the kidneys.
What is the effect of Tripin OM Tablet on the Liver?
Tripin Om is rarely harmful for the liver.
What is the effect of Tripin OM Tablet on the Heart?
Tripin Om may have mild side effects on the heart. Most people will never see any effect on the heart.
Tripin OM Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Tripin OM Tablet unless your doctor advises you to do so -
Is this Tripin OM Tablet habit forming or addictive?
Forming a habit of Tripin OM Tablet has not been reported.
Interaction between Food and Tripin OM Tablet
When consumed with certain foods, Tripin OM Tablet may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Tripin OM Tablet
Consumption of alcohol and Tripin OM Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448